[In vitro measurement of 3H thymidine uptake in Jensen sarcoma under the effect of cytostatics using fluid scintillation spectrometry].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D066298:In Vitro Techniques; D008727:Methotrexate / Q000494:pharmacology; D011874:Radiometry; D051381:Rats; D012513:Sarcoma, Experimental / Q000378:metabolism*; D013057:Spectrum Analysis; D013936:Thymidine / Q000378:metabolism*; D013997:Time Factors; D014228:Triaziquone / Q000494:pharmacology; D014316:Tritium; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D014316:Tritium; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide; D014228:Triaziquone; D013936:Thymidine; D008727:Methotrexate
In vitro-Messung des Einbes von 3H-Thymidin in Jensen Sarkom unter Cytostaticaeinwirkung mit Hilfe der Flüssigkeits-Szintillations-Spektrometrie.